Ostertagia ostertagi (Brown Stomach Worm) in Cattle: Hypobiosis, Pathogenesis, and Management

Etiology and Taxonomy

Ostertagia ostertagi is a trichostrongylid nematode of the abomasum (true stomach) of cattle. It belongs to the Order Strongylida, Superfamily Trichostrongyloidea. The parasite is colloquially termed the "brown stomach worm" due to the characteristic brownish color of adult worms visible on the abomasal mucosa. O. ostertagi is the most economically significant gastrointestinal nematode of grazing cattle in temperate regions worldwide. It is closely related to O. lyrata and O. leptospicularis, but only O. ostertagi is consistently pathogenic in cattle [1, 2].

Epidemiology and Life Cycle

The life cycle of O. ostertagi is direct, with no intermediate hosts. Adult female worms in the abomasal lumen produce eggs that pass in the feces. Eggs hatch in the environment, releasing first-stage larvae (L1) that develop through second (L2) and third (L3) infective stages on pasture. The L3 are sheathed, resistant to environmental extremes, and migrate onto herbage where they are ingested by grazing cattle.

Once ingested, exsheathment occurs in the rumen or abomasum, and L3 penetrate the gastric glands of the abomasal mucosa. There they molt to L4 and eventually emerge as L5 and adults into the lumen, completing the prepatent period of approximately 18 to 21 days under optimal conditions. However, a critical deviation in this lifecycle is the phenomenon of hypobiosis (arrested development), which is central to the epidemiology of ostertagiosis [1, 3].

Hypobiosis

Hypobiosis refers to the temporary cessation of larval development at the early L4 stage within the abomasal glands. This arrested development is triggered by environmental cues (especially decreasing temperature and photoperiod) that signal the approaching unfavorable season for larval survival on pasture. The arrested L4 remain in the gastric glands for weeks to months, retaining the ability to resume development when conditions become permissive. Resumption is often synchronized, leading to mass emergence of larvae and adults into the lumen, a phenomenon known as Type II ostertagiosis [2, 3].

The mechanistic basis of hypobiosis is not fully understood but involves complex interactions between host immunity, larval energy reserves, and neuroendocrine signaling. A key hypothesis involves the accumulation of a "dauer-like" transcriptomic program, analogous to that seen in Caenorhabditis elegans. Under field conditions, hypobiosis allows O. ostertagi to survive winter or dry seasons when pasture contamination is low. In temperate regions, larvae ingested in late autumn undergo hypobiosis until spring, when they emerge and cause severe disease in young stock [1].

Pathogenesis and Clinical Signs

There are two distinct clinical syndromes: Type I ostertagiosis and Type II ostertagiosis.

Type I Ostertagiosis

This classic form follows the ingestion of large numbers of L3 over a short period, typically in spring or early summer. Larvae penetrate the abomasal glands, causing physical damage, inflammation, and loss of parietal cell function. The resulting abomasitis leads to a rise in abomasal pH (from normal ~2 to >5), which permits bacterial overgrowth and impairs protein digestion. Clinical signs include:

• Profuse, watery diarrhea (often greenish and foul-smelling)
• Anorexia and weight loss
• Dehydration and hypoproteinemia (due to protein-losing enteropathy)
• Rough hair coat and debilitation
• Submandibular edema (bottle jaw) in severe cases

Morbidity is high in weaned calves and yearlings; mortality can occur if untreated. The pathogenesis is primarily an exudative abomasitis with hyperplasia of undifferentiated epithelial cells and loss of acid-secreting parietal cells [1, 3].

Type II Ostertagiosis

Type II results from the synchronous reactivation of hypobiotic L4 within the gastric glands. This typically occurs in late winter or early spring in temperate climates, or at the onset of the rainy season in subtropical systems. The mass emergence of developing larvae creates an acute, often explosive syndrome similar to Type I but with a more rapid onset. Clinical signs include sudden profuse diarrhea, severe dehydration, hypoproteinemia, and rapid weight loss. Mortality can be high, particularly in previously parasitized animals with poor nutritional status [2, 4].

Table 1: Contrast between Type I and Type II Ostertagiosis

Pathology

Gross pathology in acute ostertagiosis reveals an edematous, thickened abomasal mucosa with a characteristic "Morocco leather" appearance produced by raised plaques of hyperplastic lymphoid and epithelial cells around parasitized gastric glands. In chronic cases, the mucosa may appear irregular with small white nodules (early L4). In Type II, multiple emerging larvae cause a "pepper-pot" or "sandpaper" texture. Histologically, there is epithelial hyperplasia, depletion of parietal cells, and infiltration of eosinophils and mast cells [1, 3]. Abomasal pH elevation is a key biochemical lesion.

Diagnosis

Diagnosis is based on clinical signs, grazing history, seasonality, and laboratory confirmation.

• Fecal examination: Quantitative fecal flotation (e.g., modified McMaster technique) reveals typical strongyle-type eggs (thin-shelled, ellipsoidal, morulated). Eggs are morphologically indistinguishable from other trichostrongylids (e.g., Cooperia, Haemonchus). For O. ostertagi specifically, eggs per gram (EPG) counts correlate with worm burden in Type I but are unreliable in Type II due to prepatent emergence.
• Larval culture: Fecal culture to third-stage larvae (L3) allows species identification based on sheath tail morphology. O. ostertagi L3 have a long, thin tail filament with a characteristic subterminal constriction.
• Serology: Enzyme-linked immunosorbent assays (ELISAs) detecting antibodies against O. ostertagi can indicate exposure at herd level. For a detailed discussion of ELISA methodology, see the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. However, serology cannot distinguish active versus past infection.
• Necropsy: Direct examination of abomasal contents and mucosal scrapings reveals adult worms (up to 1 cm long, brownish). In cases of suspected Type II, hypobiotic L4 can be seen as tiny white nodules in the mucosa.
• Biochemistry: Hypoproteinemia, hypoalbuminemia, and elevated pepsinogen levels (pepsinogen is normally converted to pepsin in acidic pH; in ostertagiosis, pepsinogen leaks into circulation due to damaged mucosa).
• Molecular diagnostics: PCR-based assays targeting the ITS-2 region of rDNA can detect O. ostertagi DNA in feces or on pasture samples. Real-time quantitative PCR can provide species-level quantification, but such assays are not yet widely available in field practice [3].

Treatment and Management

Anthelmintic therapy remains the cornerstone of individual and group treatment. All macrocyclic lactones (avermectins/milbemycins), benzimidazoles, and imidazothiazoles (levamisole) have efficacy against adult worms and developing L4. However, hypobiotic L4 are less susceptible to some anthelmintics; benzimidazoles (e.g., fenbendazole given at higher doses for 5 days) are considered more effective against arrested larvae. Macrocyclic lactones (e.g., ivermectin, doramectin, eprinomectin, moxidectin) are also effective, but resistance to both classes has been reported globally [4].

Anthelmintic resistance to macrocyclic lactones and benzimidazoles is increasingly documented in O. ostertagi populations, particularly in regions with intensive cattle production and frequent deworming. Resistance is diagnosed via fecal egg count reduction tests (FECRT). Management of resistance requires refugia-based strategies: leaving a proportion of the herd untreated to maintain susceptible allele frequencies, and reducing treatment frequency.

For acute cases, supportive care includes:

• Fluid therapy (oral or intravenous)
• Electrolyte replacement
• Plasma transfusions in severe hypoproteinemia
• Non-steroidal anti-inflammatory drugs (NSAIDs) to reduce abomasal inflammation

Control and Prevention

Integrated parasite management (IPM) is essential. Key components include:

• Grazing management: Avoid overstocking and use rotational grazing with rest periods sufficient to reduce L3 contamination (usually >3 weeks in summer, longer in cool weather). Co-grazing or alternating with sheep or horses may reduce O. ostertagi burden as these species are not susceptible.
• Strategic deworming: In temperate zones, treat animals at housing after the first grazing season to remove hypobiotic larvae (e.g., with a benzimidazole given 5 days or with a macrocyclic lactone). This prevents Type II ostertagiosis the following spring. In some systems, a second treatment in mid-summer may be needed to reduce pasture contamination.
• Refugia-based approaches: Targeted selective treatment (TST) using clinical criteria (e.g., fecal egg count thresholds, condition score, or diarrhea score) to treat only those animals with high burdens.
• Vaccination: No commercially available vaccine exists for O. ostertagi. Experimental vaccines using excretory-secretory antigens from L3 or hidden antigens from the gut of adult worms have shown promise in trials but are not yet licensed [4].
• Biological control: Use of nematophagous fungi (e.g., Duddingtonia flagrans) fed to cattle to reduce larval survival on pasture is under investigation.
• Research into host genetics: Some breeds (e.g., N'Dama, East African Shorthorn) appear more resistant; selection for resistance is a long-term goal.

Mermaid Diagram: Life Cycle and Hypobiosis Decision Point

graph TD
    A[Adult worms in abomasal lumen], > B[Eggs in feces]
    B, > C[L1, L2, L3 on pasture]
    C, > D[Grazing cattle ingest L3]
    D, > E[Exsheathment in rumen/abomasum]
    E, > F{L3 penetration into gastric glands}
    F, > G[Development to L4 in glands]
    G, > H{Cue: decreasing temperature/photoperiod}
    H, >|Yes| I[Hypobiosis: arrested L4 in glands]
    I, > J[Cue: spring / permissive conditions]
    J, > K[Resume development to L5]
    H, >|No| K
    K, > L[Emergence into lumen]
    L, > A

    style I fill:#f9f,stroke:#333,stroke-width:2px
    style J fill:#ccf,stroke:#333,stroke-width:2px

The diagram highlights the critical decision point: environmental cues trigger hypobiosis or direct development. Inhibition of development (hypobiosis) allows the parasite to overwinter, while synchronous reactivation in spring leads to Type II disease.

Conclusion

Ostertagia ostertagi remains a major constraint to cattle production in temperate and subtropical grazing systems. The unique capacity for hypobiosis complicates both epidemiology and control. Effective management requires an integrated approach combining strategic anthelmintic use with grazing management, monitoring of resistance, and consideration of emerging molecular diagnostic tools. For further reading on related livestock parasites, see Fasciolosis in Cattle and Sheep: Liver Fluke Diagnosis via Coproantigen ELISA, Pooled PCR, and Anthelmintic Resistance to Triclabendazole and Cryptosporidiosis in Neonatal Ruminants: Molecular Diagnostics and Zoonotic Strain Surveillance. A general overview of gastrointestinal nematodes, coccidia, and flukes is available in Livestock Parasites: Clinical Approaches to Gastrointestinal Nematodes, Coccidia, and Flukes.

References

[1] Bowman DD. Georgis' Parasitology for Veterinarians. 9th ed. St. Louis: Saunders Elsevier; 2009.

[2] Zajac AM, Conboy GA. Veterinary Clinical Parasitology. 8th ed. Ames: Wiley-Blackwell; 2012.

[3] Eysker M, Ploeger HW. The use of diagnostic markers to monitor the epidemiology of gastrointestinal nematodes in cattle. Veterinary Parasitology. 2008;158(1-2):1-12.

[4] Vercruysse J, Claerebout E. Ostertagia ostertagi: a review of recent developments in immunology, pathogenesis and control. Veterinary Parasitology. 1996;62(3-4):203-223.